N

Minerva Neurosciences
D

NERV

1.72000
USD
0.01
(0.58%)
مغلق
حجم التداول
0
الربح لكل سهم
-3
العائد الربحي
-
P/E
2
حجم السوق
12,028,658
أصول ذات صلة
A
ANVS
0.01000
(0.42%)
2.41000 USD
C
CRVS
-0.03500
(-0.88%)
3.95500 USD
C
CYCC
-0.01980
(-7.76%)
0.23520 USD
M
MGTX
0.56000
(8.07%)
7.50000 USD
NTRA
NTRA
-0.270
(-0.17%)
161.300 USD
X
XNCR
0.09500
(1.14%)
8.40000 USD
المزيد
الأخبار المقالات

العنوان: Minerva Neurosciences

القطاع: Healthcare
الصناعة: Biotechnology
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.